BIOXCEL THERAPEUTICS INC (BTAI) Institutional Ownership and Insiders Activity

BIOXCEL THERAPEUTICS INC (BTAI) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $323,193 based on SEC Form 13F filings for the quarter ended March 31, 2026.

Oaktree Capital Management is the largest disclosed holder, reporting approximately $323,193 in BTAI holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Oaktree Capital Management representing the majority of disclosed value.

Recent insider activity includes 16 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.